Development of a broadly protective neuraminidase-based Influenza Virus vaccine

Authors

• Irene Hoxie, Icahn School of Medicine at Mount Sinai, USAFollow
• Kirill Vasilev, Department of Microbiology, Icahn School of Medicine at Mount Sinai
• Madhumathi Loganathan, Department of Microbiology, Icahn School of Medicine at Mount Sinai
• Benjamin Francis, Department of Microbiology, Icahn School of Medicine at Mount Sinai
• Jordan Clark, Department of Microbiology, Icahn School of Medicine at Mount Sinai
• Jay Evans, Center of Translational Medicine, University of Montana, MT, USA
• David Burkhart, Center of Translational Medicine, University of Montana, MT, USA
• Florian Krammer, Department of Microbiology, Icahn School of Medicine at Mount Sinai

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Irene Hoxie, Kirill Vasilev, Madhumathi Loganathan, Benjamin Francis, Jordan Clark, Jay Evans, David Burkhart, and Florian Krammer, "Development of a broadly protective neuraminidase-based Influenza Virus vaccine" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/78